Composition
- Active ingredients
- MOXETUMOMAB PASUDOTOX-TDFK 1MG/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761104.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lumoxiti
- Active substance
- moxetumomab pasudotox-tdfk
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Innate Pharma
- Status
- Prescription
- FDA approval
- 13 Sept 2018
- Application
- BLA761104-001